1. Home
  2. RLMD vs LBGJ Comparison

RLMD vs LBGJ Comparison

Compare RLMD & LBGJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • LBGJ
  • Stock Information
  • Founded
  • RLMD 2004
  • LBGJ 2007
  • Country
  • RLMD United States
  • LBGJ China
  • Employees
  • RLMD N/A
  • LBGJ N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • LBGJ
  • Sector
  • RLMD Health Care
  • LBGJ
  • Exchange
  • RLMD Nasdaq
  • LBGJ NYSE
  • Market Cap
  • RLMD 22.0M
  • LBGJ 24.7M
  • IPO Year
  • RLMD N/A
  • LBGJ 2024
  • Fundamental
  • Price
  • RLMD $0.61
  • LBGJ $1.25
  • Analyst Decision
  • RLMD Buy
  • LBGJ
  • Analyst Count
  • RLMD 3
  • LBGJ 0
  • Target Price
  • RLMD $5.00
  • LBGJ N/A
  • AVG Volume (30 Days)
  • RLMD 338.9K
  • LBGJ 10.1K
  • Earning Date
  • RLMD 08-06-2025
  • LBGJ 08-15-2025
  • Dividend Yield
  • RLMD N/A
  • LBGJ N/A
  • EPS Growth
  • RLMD N/A
  • LBGJ N/A
  • EPS
  • RLMD N/A
  • LBGJ N/A
  • Revenue
  • RLMD N/A
  • LBGJ $11,781,015.00
  • Revenue This Year
  • RLMD N/A
  • LBGJ N/A
  • Revenue Next Year
  • RLMD N/A
  • LBGJ N/A
  • P/E Ratio
  • RLMD N/A
  • LBGJ N/A
  • Revenue Growth
  • RLMD N/A
  • LBGJ 21.82
  • 52 Week Low
  • RLMD $0.24
  • LBGJ $1.02
  • 52 Week High
  • RLMD $4.47
  • LBGJ $5.50
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 47.74
  • LBGJ N/A
  • Support Level
  • RLMD $0.60
  • LBGJ N/A
  • Resistance Level
  • RLMD $0.69
  • LBGJ N/A
  • Average True Range (ATR)
  • RLMD 0.07
  • LBGJ 0.00
  • MACD
  • RLMD -0.01
  • LBGJ 0.00
  • Stochastic Oscillator
  • RLMD 41.86
  • LBGJ 0.00

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About LBGJ LI BANG INTERNATIONAL CORPORATION I

Li Bang International Corp Inc is a holding company. The firm through its subsidiaries engages in designing, developing, producing, and selling stainless steel commercial kitchen equipment in China under its own Libang brand. In addition, its subsidiaries provide customers with comprehensive services, from commercial kitchen design in the early stage to equipment installation and after-sales maintenance.

Share on Social Networks: